New Anal Cancer Clinical Trial: Paclitaxel for Anal Cancer

NCI Minute: Study Finds Promising Results for Treating Anal Cancer in People Living with HIVПодробнее

Study shows better option for treatment of inoperable anal cancerПодробнее

State of the Science: Clinical Trials for Anal Cancer Stages I - IIIПодробнее

Checkpoint inhibitors in anal cancerПодробнее

Cathy Eng, MD - Anal cancer's first randomized trial for inoperable disease the treatment standardПодробнее

What is New in Anal Cancer in the Last 12 Months?Подробнее

State of the Science: Metastatic Anal Cancer Treatment & Research UpdatesПодробнее

Clinical Trials for Recurrent and Metastatic Anal Cancer with Cathy Eng, MD, FACP, FASCOПодробнее

State of the Science: Treatment for Metastatic Anal CancerПодробнее

Standard of Care for Recurrent and Metastatic Anal Cancer with Paul Romesser, MDПодробнее

Thriver Story - LillianПодробнее

Using immunotherapy to treat anal cancerПодробнее

Introduction to Anal Cancer: State of the ScienceПодробнее

Anal Cancer ThriversПодробнее

Pembrolizumab Shows Durable Response in Advanced Unresectable Anal CancerПодробнее

Investigating PD-L1 expression as a biomarker in anal cancer trialsПодробнее

Immunotherapy plus targeted therapy for metastatic anal cancer treatmentПодробнее

What is new in anal cancer in the last 12 months?Подробнее